The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Practice gaps and challenges integrating new immuno-oncology agents in the treatment of cancer patients in the United States: A mixed-method study.
 
Neal E. Ready
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; G1 Therapeutics; Genentech; Merck; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; G1 Therapeutics; Genentech; Merck; Roche
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - Merck
Expert Testimony - Bristol-Myers Squibb; Celgene
 
Aparna Raj Parikh
Consulting or Advisory Role - Driver, Inc; Foundation Medicine; Lilly; Natera; PureTech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); Tesaro (Inst); Tolero Pharmaceuticals (Inst)
 
Patrice Lazure
No Relationships to Disclose
 
Morgan Peniuta
No Relationships to Disclose
 
Marianne Davies
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck
 
Monica Augustyniak
No Relationships to Disclose
 
Jeffrey Caterino
Stock and Other Ownership Interests - Motive Medical Intelligence
Consulting or Advisory Role - Wellstat Therapeutics
Research Funding - AstraZeneca; Entegrion; JDP Therapeutics; Stago
 
Robert Lewandowski
Consulting or Advisory Role - Bard Medical; BMS Brazil; Boston Scientific; BTG
Speakers' Bureau - BTG
Research Funding - Siemens
 
Alexander J. Lazar
Leadership - Archer; Iterion Therapeutics; Nucleai
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Deciphera; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Suzanne Murray
No Relationships to Disclose